List of SBIR/STTR awards granted to NEOCLONE BIOTECHNOLOGY INTERNATIONAL
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to NEOCLONE BIOTECHNOLOGY INTERNATIONAL for $140,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA126070-01A1 | Phase I | 140,000 | ||||||||
A SBIR Phase I contract was awarded to NEOCLONE BIOTECHNOLOGY INTERNATIONAL for $286,368.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA162789-01A1 | Phase I | 286,368 | ||||||||
A SBIR Phase II contract was awarded to NEOCLONE BIOTECHNOLOGY INTERNATIONAL for $35,615.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CN733001 | Phase II | 35,615 | ||||||||
A SBIR Phase I contract was awarded to NEOCLONE BIOTECHNOLOGY INTERNATIONAL for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CN433013 | Phase I | 100,000 | ||||||||
A STTR Phase I contract was awarded to NEOCLONE BIOTECHNOLOGY INTERNATIONAL for $190,591.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA132520-01A2 | Phase I | 190,591 | ||||||||
A SBIR Phase I contract was awarded to NEOCLONE BIOTECHNOLOGY INTERNATIONAL for $99,635.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA128752-01 | Phase I | 99,635 | ||||||||
A SBIR Phase I contract was awarded to NEOCLONE BIOTECHNOLOGY INTERNATIONAL for $507,208.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CN73301 | Phase I | 507,208 | ||||||||
A SBIR Phase I contract was awarded to NEOCLONE BIOTECHNOLOGY INTERNATIONAL for $507,208.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CN73301 | Phase I | 507,208 | ||||||||
A SBIR Phase II contract was awarded to NEOCLONE BIOTECHNOLOGY INTERNATIONAL for $206,777.0 USD from the U.S. Department of Health & Human Services. | SBIR | N44CN0733001 | Phase II | 206,777 |
